211 participants
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2018-04-17
- Completion:
- 2021-02-26
Conditions
- Leukemia, Lymphocytic, Chronic, B-Cell
Interventions
- DRUG